Experiment 416889

Worktypes

PHARMACOLOGY OF COMPOUND - IN HUMANSPATENT DESCRIBEDANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)

Compounds isolated

PAPULACANDIN DPAPULACANDIN CPAPULACANDIN EPAPULACANDIN BPAPULACANDIN A

Alerts

BIOLOGICAL ACTIVITY REPORTED HAS BEEN PATENTED.DATA INCOMPLETE - DERIVED FROM AN ABSTRACT.

Details

PropertyValue
Pharmacology
ANTIPROTOZOAN ACTIVITY
Administration routeORAL
OrganismEmpty organism
CitationSCHMATZ,DM:. (1990). PAPULACANDINS FOR THE CONTROL OF PNEUMOCYSTIS CARINII INFECTIONS.. ()
Amount utilized
Compound isolated
DiseaseMEDICATIONS WERE PREPARED FOR THE TREATMENT OF PNEUMOCYSTIS CARINII INFECTIONS IN AIDS PATIENTS.
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Dose expressionDOSE